Winton Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $930K | Buy |
28,159
+3,904
| +16% | +$129K | 0.05% | 453 |
|
|
2025
Q1 | $975K | Buy |
24,255
+5,250
| +28% | +$211K | 0.06% | 432 |
|
|
2024
Q4 | $894K | Buy |
19,005
+9,210
| +94% | +$433K | 0.06% | 372 |
|
|
2024
Q3 | $517K | Sell |
9,795
-8,354
| -46% | -$441K | 0.04% | 438 |
|
|
2024
Q2 | $983K | Buy |
+18,149
| New | +$983K | 0.07% | 250 |
|
|
2024
Q1 | – | Sell |
-17,596
| Closed | -$1.47M | – | 663 |
|
|
2023
Q4 | $1.47M | Buy |
+17,596
| New | +$1.47M | 0.11% | 145 |
|
|
2023
Q2 | – | Sell |
-11,380
| Closed | -$400K | – | 850 |
|
|
2023
Q1 | $400K | Buy |
11,380
+1,000
| +10% | +$35.2K | 0.02% | 757 |
|
|
2022
Q4 | $476K | Buy |
10,380
+3,403
| +49% | +$156K | 0.03% | 648 |
|
|
2022
Q3 | $338K | Sell |
6,977
-297
| -4% | -$14.4K | 0.02% | 757 |
|
|
2022
Q2 | $286K | Buy |
+7,274
| New | +$286K | 0.02% | 815 |
|
|
2022
Q1 | – | Sell |
-6,868
| Closed | -$313K | – | 995 |
|
|
2021
Q4 | $313K | Buy |
+6,868
| New | +$313K | 0.02% | 816 |
|